Anna deFazio heads the Gynaecological Oncology Research Laboratory at the Centre for Cancer Research, the Westmead Institute for Medical Research. Anna holds the Sydney-West Chair in Translational Cancer Research, University of Sydney, at Westmead Hospital, and has a long-standing commitment to translational research with an emphasis on improving treatment outcomes for women with ovarian cancer. She completed her PhD at the Ludwig Institute for Cancer Research, University of Sydney, undertook postdoctoral studies at the Garvan Institute and established a program of ovarian cancer research at Westmead in 1995. Anna is on the Executive of the Sydney-West Translational Cancer Research Centre and is an investigator on a number of national and international collaborative consortia including the Australian Ovarian Cancer Study (AOCS), the Australasian Biospecimen Network (ABN-Oncology), the International Cancer Genome Consortium (ICGC), the Ovarian Cancer Association Consortium (OCAC) and the NSW PRIMe (Pharmacogenomics Research for Individualised Medicine) consortium.


Gynaecological cancer, Cancer, Women's health, Ovarian cancer



Research Focus

The focus of Anna’s research is to understand the clinical and genetic factors that influence response and resistance to chemotherapy in ovarian cancer.

Other Affiliations

Faculty of Medicine and Health > Westmead Clinical School > Westmead Clinical School

Awards and Recognition

  • 2012 - Clinical Associate Professor, Discipline of Obstetrics, Gynaecology & Neonatology, Sydney Medical School – Westmead
  • 1999 - Clinical Senior Lecturer, Discipline of Obstetrics, Gynaecology & Neonatology, Sydney Medical School - Westmead
  • 2013 - Professor, Sydney Medical School- Westmead



  • BSc (Hons I), Biochemistry, UNSW Australia, Sydney
  • PhD, Cancer Medicine, University of Sydney, Sydney